Reportlinker.com announces that a new market research report is available in its catalogue: Proteomics - International Market Trends
http://www.reportlinker.com/p0164204/Proteomics---International-Market-Trends.html
The shift from genomics to proteomics paves way for technological advancements assisting drug discovery researchers by offering added sensitivity, increased throughput and increased resolution from traditional protein research tools. A major market growth driver is the explosion in scientific discoveries arising from the human genome project and from advances in high-throughput technologies for protein studies. Companies from diverse areas such as contract research, computational science, outsourced drug discovery services, database administration and integration, software manufacture, genomics and genetics, operate in the industry.
These and other market data and trends are presented in "Proteomics: International Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
PROTEOMICS BMR-1004
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL MARKET OVERVIEW 4
Current Spotlight 4
Genesis of Proteomics 4
Proteomics: A Critical Drug Discovery Tool 4
Factors Influencing the Market 6
Market Drivers 6
Transition from Genomics to Proteomics 6
Industrialization of Proteomics Research 6
International Initiatives Light-up Proteomics Market 6
Factors Limiting Market Growth 6
Major Challenges 7
Proteomics Sample Preparation Market 7
Protein Chemistry and its Complexities 7
Integration of Data & Equipment 7
Data Validation - A Burning Issue 7
Standardization & Consistency - A Prime Concern 7
3. INDUSTRY COMPETITION 8
Industry Participants 8
Proteomics Market Worldwide: Competitive Landscape 9
Proteomics Supplier Market 9
Proteomics Product and Service Suppliers 10
Challenges Ahead 10
Designing a Novel Business Model 11
4. PRODUCT FACTS 12
Expression Proteomics 12
Functional Proteomics 12
Structural Proteomics 12
5. END-USE APPLICATION AREAS 13
Proteomics and Drug Discovery 13
Proteomic Approaches Gaining Prominence in Cancer Drug Discovery 14
Proteomics Technologies Used in Cancer Drug Discovery and
Development 15
Advancements in Proteomics Bring Biomarkers into Limelight 15
Leading Companies in Proteomics-Based Drug Discovery 16
Future of Proteomics in Drug Discovery 16
6. CORPORATE DEVELOPMENTS 16
Sigma-Aldrich Enters Exclusive Alliance with Atlas Antibodies
to Distribute Prestige Antibodies™ 16
Nonlinear Dynamics Inks Distribution Agreement with UVP, LLC 17
Plexera Enters into Access Agreement with Auguron for NAPPA 17
NextGen and Paragon Bioservices Enter into a Commercial
Partnership Agreement 17
Bruker Daltonics Introduces Advanced ETD II Module 18
Applied Biosystems Expands its iTRAQ® Line of Labeling Reagents 18
Digilab Acquires Genomic Solutions and MAIA Scientific from
Harvard Bioscience 18
Power3 Ropes in FAH to Distribute its BC- SeraPro™ in the
Middle East 18
Thallion Sells Majority Stake to US-based Private Equity Firm,
Great Point Partners 19
Ecopia and Caprion Merge to Form Thallion Pharmaceuticals 19
BG Medicine and Applied Biosystems Collaborate for Biomarker
Discovery and Development 19